Ginkgo Bioworks Holdings (DNA) Other Non-Current Liabilities (2020 - 2026)

Ginkgo Bioworks Holdings has reported Other Non-Current Liabilities for 7 years, with the latest figure at $21.7 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Liabilities rose 40.84% year-over-year to $21.7 million; the trailing twelve-month figure through Mar 2026 stood at $21.7 million (up 40.84% YoY), and the FY2025 full-year result was $22.9 million, up 38.01% from the prior year.
• Other Non-Current Liabilities for Q1 2026 stood at $21.7 million, down from $22.9 million in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $50.8 million in Q1 2022, with the low at $10.9 million in Q4 2022.
• Historically, Other Non-Current Liabilities has averaged $23.5 million across 5 years, with a median of $20.9 million in 2024.
• Annual changes were most pronounced in 2022 — Other Non-Current Liabilities sank 80.99% — and 2023, when it jumped 124.82%.
• Ginkgo Bioworks Holdings' Other Non-Current Liabilities stood at $10.9 million in 2022, then surged by 124.82% to $24.4 million in 2023, then slumped by 32.16% to $16.6 million in 2024, then surged by 38.01% to $22.9 million in 2025, then dropped by 5.0% to $21.7 million in 2026.
• The last three Other Non-Current Liabilities figures came in at $21.7 million (Q1 2026), $22.9 million (Q4 2025), and $17.2 million (Q3 2025), per Business Quant data.